BioAscent

@bioascent.bsky.social

Science-led integrated drug discovery: medicinal and synthetic chemistry, computational chemistry, in vitro biosciences, DMPK, compound management and diversity and fragment libraries. Scotland, UK.

BioAscent has been profiled in Business Focus Magazine. With insight from BioAscent's Director of Biosciences, Stuart McElroy, the feature charts our journey from our establishment in 2013 to becoming a recognised leader in integrated drug discovery services. Find out more: https://bit.ly/3JJZq92

Bild

At BioAscent, we bring decades of combined experience to help our customers solve complex problems. Our integrated approach focuses on working efficiently rather than taking shortcuts, allowing us to shorten timelines and enhance candidate quality. Find out more: https://bit.ly/44sYm1d

Bild

Developing molecules requires a team that asks the right questions, thinks creatively and tackles challenges head-on. Our seasoned chemists combine their deep expertise with innovative thinking to accelerate our customers' drug discovery journeys. Find out more: https://bit.ly/44sYm1d

Identifying covalent inhibitors for challenging targets. We developed a robust high-throughput screening (HTS) assay that successfully differentiated false positives from true hits, even amidst common synthesis contaminants. View the poster to learn more: https://bit.ly/43UrNsX

Bild

At BioAscent, we bring decades of combined experience to help our customers solve complex problems. Our integrated approach focuses on working efficiently rather than taking shortcuts, allowing us to shorten timelines and enhance candidate quality. Find out more: https://bit.ly/44sYm1d

Bild